CAMLG and endometrial endometrioid adenocarcinoma: Figure 5 shows a representative photomicrograph of both tiny and giant CAML identified by triple immunofluorescence as well as by double immunocytochemistry from the blood samples from a patient with endometrial endometrioid adenocarcinoma with Stage IA and Grade 1 disease at the time of surgery.